In this study, we observed a significant upregulation of GDF6 in hypertrophic hearts and NRVMs, and that GDF6 overexpression or supplementation effectively blocked TAC- or PE-induced cardiac hypertrophy in vivo and in vitro. The gene discussed is GDF6; the disease is cardiac hypertrophy.